ORIGINAL RESEARCH article

Front. Microbiol., 23 June 2015

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 6 - 2015 | https://doi.org/10.3389/fmicb.2015.00601

Occurrence of classes I and II integrons in Enterobacteriaceae collected from Zagazig University Hospitals, Egypt

  • 1. Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University Cairo, Egypt

  • 2. Pediatrics Department, Faculty of Medicine, Zagazig University Zagazig, Egypt

Abstract

Integrons are genetic units characterized by the ability to capture and incorporate gene cassettes, thus can contribute to the emergence and transfer of antibiotic resistance. The objectives of this study were: (1) to investigate the presence and distribution of class I and class II integrons and the characteristics of the gene cassettes they carry in Enterobacteriaceae isolated from nosocomial infections at Zagzig University Hospital in Egypt, (2) to determine their impact on resistance, and (3) to identify risk factors for the existence of integrons. Relevant samples and full clinical history were collected from 118 inpatients. Samples were processed; isolated microbes were identified and tested for antibiotic susceptibilities. Integrons were detected by polymerase chain reaction (PCR) and were characterized into class I or II by restriction fragment length polymorphism (RFLP). Integron-positive isolates were subjected to another PCR to detect gene cassette, followed by gene cassette sequencing. Risk factors were analyzed by logistic regression analysis. Seventy-six Enterobacteriaceae isolates were recognized, 41 of them (53.9%) were integron-positive; 39 strains carried class I and 2 strains carried class II integrons. Integrons had gene cassettes encoding different combinations and types of resistance determinants. Interestingly, blaOXA129 gene was found and ereA gene was carried on class I integrons. The same determinants were carried within isolates of the same species as well as isolates of different species. The presence of integrons was significantly associated with multidrug resistance (MDR). No risk factors were associated for integron carriage. We conclude that integrons carrying gene cassettes encoding antibiotic resistance are significantly present among Enterobacteriaceae causing nosocomial infection in our hospital. Risk factors for acquisition remain to be identified.

Introduction

The widespread use of antibiotics with the intra- and inter-species transfer of resistant determinants mediated by plasmids, transposons and gene cassettes in integrons have contributed to the rapid transmission of drug resistance in bacterial pathogens, especially among members of the Enterobacteriaceae family (Cergole-Novella et al., 2011). Integrons are mobile DNA elements capable of detention and excision of genes, particularly those responsible for antibiotic resistance. Integrons achieve this by site-specific recombination (Hall and Collis, 1995). The different combinations of gene cassettes can contribute to the diverse genetic organization of integrons. There are five different classes of integrons, each encoding a distinct integrase gene (Mazel, 2006). Class I integrons are the most common type present in clinical isolates of the Enterobacteriaceae (DeLappe et al., 2003). Class II integrons are associated with the Tn7 transposon, whose transposition activity is directed at specific attachment sites on chromosomes or plasmids (Rodríguez-Minguela et al., 2009). Although the class II integrons share their cassettes pool with the class I integrons, they are distinguished by divergent integrase sequences (Gillings, 2014). Class I integron possess two conserved segments (5′-CS) and (3′-CS) separated by a variable region including the gene cassettes integrated with antibiotic resistant genes. The 5′-CS consists of (intI) gene codes for integrase, adjacent recombination site (att1) recognized by the integrase and acts as a receptor for gene cassettes, and the promoter (P) which controls the transcription of integrated resistance markers, as these genes do not have their own promoters (Mazel, 2006). The 3′-CS usually includes truncated qacE (qacED1) and sul1 genes that confer resistance to quaternary ammonium compounds and sulfonamides, respectively (Paulsen et al., 1993). Gene cassettes typically comprise of a recombination site (attC) and a single-promoter-less gene, most of which encode antibiotic resistance factors (Partridge et al., 2009). Class I integron has been identified as the primary source of antimicrobial resistance genes and are suspected to serve as reservoirs and exchange platforms of resistant genes in a variety of Gram-negative bacteria (Ke et al., 2011).

During the last months, there were complaints from clinicians about the emergence and dissemination of MDR in the intensive care unit (ICU), the orthopedic unit, the neonatology unit and the chest unit. This resistance causes treatment failure, morbidity and sometimes mortality. Preliminary investigations pointed out the possibility of integrons (among other mechanisms of resistance). To the best of our knowledge, little is known about the integrons and their associated gene cassettes in Enterobacteriaceae isolates in our hospital specifically, in Egypt generally. In order to provide helpful base-line information for further comparison with follow up studies, we thus conducted the current work. The objectives were: (1) to investigate the presence and distribution of class I and class II integrons and the characteristics of the gene cassettes they carry in Enterobacteriaceae isolated from nosocomial infection cases at Zagzig University Hospital, (2) to determine their impact on resistance, and (3) to identify risk factors of the existence of integrons.

Materials and methods

Subjects

Over a period of 23 months (May 2012–March 2014), 118 in-patients were enrolled from different clinical departments at Zagazig University Hospital. Patients were included only if they are suspected to have hospital-acquired infection (Horan et al., 2008) and the laboratory results reported Gram-negative bacilli from the infection sites. Clinical units selected were those reported to the Infection Control Unit as having increased incidence of infections caused by resistant-Enterobacteriaceae. The demographic and clinical data was collected from all patients.

Ethical consideration

An informed written consent was taken from each individual after explaining the nature of investigation as well as the purpose of the study in accordance with the ethical standards of the responsible Regional Committee. Participants' data is confidential. Institutional approval was obtained from the Institutional Review Board (IRB) committee.

Study design

Observational cross sectional study.

Clinical samples

Clinical samples were collected by systematic random sampling. The origin and type of samples are shown in Table 1. Samples were collected and processed using standard Microbiologic procedures (Collee and Marr, 1996; Raul and Melvin, 2001; Cheesbrough, 2004; Forbes et al., 2007); isolated microbes were identified by colonial characteristics, Gram stain and conventional biochemical tests and confirmed by the API 20E Identification System (bioMerieux, France).

Table 1

OriginNo. and types of samplesEnterobactericae isolates
Endotracheal aspirationUrineSwabs from pusBloodTotal
ICU82111125242(80.8%)
Orthopedic unit94138(61.5%)
Neonatology unit10106(60%)
Chest unit5442158(53.3%)
Surgery unit17112812(42.9%)
Total1351302411876(64.4%)

Origin and type of the strains included in the study.

Antibiotic susceptibility

Antimicrobial susceptibility profiles of the isolates were determined using the disk diffusion method according to the standard procedures of the Clinical and Laboratory Standards Institute (CLSI, 2013). Escherichia coli (ATCC25922) (Microbiologics, USA) was used as the quality control strain. The following 17 antibiotic discs (Oxoid) were used: amikacin, amoxicillin+clavulanic acid, ampicillin+sulbactam, azithromycin, cefepime, cefixime, cefotaxime, cefoxitin, cefperazone, ceftazidime, ceftriaxone, chloramphenicol, gentamycin, imipenem, levofloxacin, meropenem, and trimethoprim-sulphamethexazole. MDR was defined according to the guidelines of the European Society of Clinical Microbiology and Infectious Diseases (Magiorakos et al., 2012).

Molecular characterization of isolated Enterobacteriaceae

Integrons detection

DNA was extracted from overnight cultures grown on MacConkey's agar, using the QIAamp DNA Mini Kit (QIAGEN, USA), according to the manufacturer's instructions. The DNA was quantified following the recommendations of Surzycki (2000).

PCR detection of integrons

Integrons were detected by PCR with the degenerate primers designed to hybridize conserved regions of encoded integrase genes intI1, intI2, hep35 (5′-TGCGGGTYAARGATBTKGATTT-3′), and hep36 (5′-CARCACATGCGTRTARAT-3′) give a PCR product of 491 bp (White et al., 2001).

RFLP for differentiation of class I and class II integrons

Digestion of PCR product

Using Rsa I restriction enzyme (White et al., 2001), PCR products were subjected to digestion with Rsa I as follow, 10 μl of the amplified gene segment, 2 μl of the l0x buffer supplied, 1 μl of the enzyme and complete reaction with sterile water to attain the final volume of 20 μl, which was incubated for 3 h at 37°C. Then, the total volume was loaded on the agarose gel. After digestion, integrase I gave rise to one fragment of 491 bp, while integrase II gave rise to two fragments of 334 and 157 bp, respectively.

Amplification of gene cassettes of class I and class II integrons

Class I integron cassette structures were amplified using hep58 (5′-TCATGGCTTGTTATGACTGT3-3′) and hep59 (5′-GTAGGGCTTATTATGCACGC-3′) which bind 3′-CS and 5′-CS conserved segments, respectively. Class II integron cassette regions were amplified using hep74 (5′-CGGGATCCCGGACGGCATGCACGATTTGTA-3′), which binds to attI2 and hep51 (5′-GATGCCATCGCAAGTACGAG-3′), which binds to orfX situated downstream of the cassette region within Tn7 (GenBank accession number AJ002782) (White et al., 2001). PCR was performed for 30 cycles, each cycle consisted of 94°C for 30 s, 55°C for 30 s and extension at 72°C for 45 s for amplification of the integrase genes, or 4 min for amplification of the cassette region. Amplification cycles were performed with DNA thermal cycler (Biometra, Germany), as mentioned elsewhere (White et al., 2000). For each batch of PCR reactions, a positive and negative control was included. Positive control was an isolate confirmed as integrase positive by DNA sequencing. PCR products were analyzed in parallel with a DNA MW-marker (Fermentas) by electrophoresis on 2% agarose gel.

DNA sequencing

Sequencing reactions were performed through using the BigDye Terminator version 3.1 Cycle Sequencing Kit (Applied Biosystems). Each reaction mixture contained 8 μl of the BigDye Terminator ready reaction mixture and 3.2 pmol of primer in a 20 μl reaction mixture. The PCR products of inserted gene cassettes within class I intgrons were sequenced using primers hep58, 5′-TCATGGCTTGTTATGACTGT-3′ and hep59, 5′-GTAGGGCTTATTATGCACGC-3′. The PCR program for all sequencing reactions included initial denaturation at 96°C for 1 min, followed by 25 cycles of denaturation for 30 s at 96°C, primer annealing for 5 s at 55°C, and extension for 4 min at 60°C according to the BigDye Terminator v3.1 Cycle Sequencing Kit Protocol Manual. The resulting sequences were identified by partial nucleotide sequencing and compared with the sequences in the GenBank database of the National Center for Biotechnology Information via the BLAST network service (http://blast.ncbi.nlm.nih.gov/Blast.cgi) (Li et al., 2013). MEGABLAST model of BLAST program was used. The best Blast Hits on our Query nucleotide sequence was selected based on the highest identity in the gene bank database.

Statistical analysis

Collected data were computerized and statistically analyzed using SPSS program (Statistical Package for Social Science) version 18.0. Qualitative data were represented as frequencies and relative percentages. Chi square test was used to calculate difference between qualitative variables. Quantitative data were expressed as mean ± SD (Standard deviation). Multivariate logistic regression analysis was used to illuminate the interrelation within and between significant predictors for specific variable. The level of significance for all statistical tests was determined. The threshold of significance is fixed at 5% level (P-value); P > 0.05 indicates non-significant results, P-value of <0.05 indicates significant results.

Results

Seventy-six Enterobacteriaceae isolates were studied. They were recovered from different clinical samples collected from 118 in-patients admitted to different departments at Zagazig University Hospitals (Table 1). The highest rate of isolating Enterobacteriaceae was from ICU (42 out of 76).

Characterization of different species of Enterobacteriaceae is shown in Figure 1. Klebsiella pneumoniae was the most common organism isolated (50.6%). Integrons were identified in 41 (53.9%) out of the 76 strains studied (Table 2). Thirty-nine (39) carried class I integron and 2 strains carried class II integron Figures 2, 3.

Figure 1

Table 2

Enterobacteriaceae isolatesClass IClass IITotal
OrganismNo.No. (%)No. (%)No. (%)
Klebsiella pneumonia4017 (42.5)1 (2.5)18 (45)
Escherichia coli1814 (77.8)1 (5.5)15 (83.3)
Enterobacter cloaca31 (33.3)2 (66.6)
Citrobacter freundii21 (50)1 (50)
Serratia marcescens21 (50)1 (50)
Morganella morgani10 (0.0)0 (0.0)
Proteus mirabialis63 (50)3 (50)
Proteus vulgaris31 (33.3)1 (33.3)
Citrobacter breakie10 (0.0)0 (0.0)
Total7639 (51.32)2 (2.6)41 (53.9)

Detection of class I and class II integrons by PCR–RFLP.

Figure 2

Figure 3

Sequencing of PCR product of gene cassettes carried on class I integron revealed different combination of gene cassettes encoding the different types of resistance determinants. Interestingly, blaOXA129 gene was found and ereA gene was detected on class I integrons. The same determinants were carried within isolates of the same species as well as isolates of different species (Table 3).

Table 3

Bacterial speciesGene cassette(s)No.
K. pneumoniadfrA14-arr2-cmiA 52
blaOXA-1-aac A6-dfrA 52
dfrA5-aph 31a2
dfrA5-TEM−11
OXA 129-dfrA5-aacA41
dfrA3
aacC1-aadA11
aadA1-dfrA13
aadA22
aadA-qac-e2
E. coliaadB1
aadA1-dfrA12
AadA3
aac6 II-2
ere A2-dfr A52
Not determined2
P. mirabilisere A2-dfr A52
Not determined1
E. cloacadfr A51
DfrA1-aadA21
S. marcescensblaP1-aadB1
C. freundiidfrA-aadA5-qac-e1
P. vulgarisOXA 129-dfrA5-accA41

Occurrence and characterization of gene cassettes carried by of class I integrons.

dfr, Dihydrofolate reductases; arr, rifampicin resistance; cmi, chloramphenicol resistance protein; OXA, oxasillinase; aac, aminoglycoside acetyltransferases; aph, 3-O-phosphotransferase; aad, aminoglycoside adenylyltransferases B; qac, quaternary ammonium compound; TEM, beta lactamase gene; bla P, beta lactamase gene.

Isolates harboring integrons were more likely to be resistant to amikacin, cefepime, ceftazidime, ceftriaxone, chloramphenicol, gentamycin, levofloxacin, and trimethoprim-sulphamethexazole than those without integrons (Table 4). All Enterobacteriaceae isolates were sensitive to both imipenem and meropenem; therefore, carbapenems group was excluded from statistical analysis. Fifty-one isolates were found to be MD-resistant (Table 5). A significant statistical association was found between MDR and the presence of integrons (Table 6).

Table 4

AntibioticResistantIntegron +veP
No.(%)No.(%)
Amikacin2231.51881.80.0164
Amoxicillin+clavulanic761004052.60.779
Ampicillin+sulbactam6686.83535.030.7634
Azithromycin6484.23554.70.646
Cefepime4761.83370.30.0302
Cefixime3444.71852.90.731
Cefotaxime4559.22555.60.586
Cefoxitin2532.81144.00.806
Cefperazone5167.13670.60.169
Ceftazidime4457.82965.90.0163
Ceftriaxone5369.73973.60.006
Chloramphenicol2026.31680.00.0293
Gentamycin2928.92379.30.0108
Levofloxacin1114.41090.90.0273
Trimethoprim-sulphamethexazole4863.13981.30.001

Association between antibiotic resistance and integron positivity.

Level of significance: P < 0.05 indicates significant results.

Table 5

Bacterial isolatesAntimicrobial categoriesMDR(51)
Integron+ve (33)Integron −ve (18)
Klebsiella pneumoniaeAminoglycosides, extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors, chloramphenicol, cephamycins51
Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors, cephamycins84
Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+b-lactamase, quinolones, aminoglycosides30
Penicillins+b-lactamase inhibitors, chloramphenicol, cephamycins11
Extended-spectrum cephalosporins, penicillins+β-lactamase inhibitors, chloramphenicol, cephamycins04
Escherichia coliPenicillins+β-lactamase inhibitors, chloramphenicol, cephamycins32
Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors, quinolones21
Aminoglycosides, extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors, Chloramphenicol, Cephamycins21
Proteus mirabilisExtended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors12
Folate pathway inhibitors, penicillins+β-lactamase inhibitors, cephamycins10
Proteus vulgarisAminoglycosides, extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors, chloramphenicol, cephamycins10
Aminoglycosides; folate pathway inhibitors, penicillins+β-lactamase inhibitors, chloramphenicol, cephamycins, quinolones11
Serratia marcescensAminoglycosides, extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors, chloramphenicol, cephamycins10
Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors, cephamycins, quinolones10
Citrobacter freundiiAminoglycosides, Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors, cephamycins10
Enterobacter cloacaFolate pathway inhibitors, penicillins+β-lactamase inhibitors, cephamycins, quinolones, chloramphenicol11
Morganella morganiAminoglycosides, Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase inhibitors, chloramphenicol cephamycins10

Resistance profile of 51 MDR* isolate.

*

Categories used in this table to identify MDR are those recommended by the European Society of clinical Microbiology and Infectious Diseases (Magiorakos et al., 2012): 1, aminoglycosides: gentamicin, amikacin; 2, carbapenems: imipenem, meropenem; 3, extended-spectrum cephalosporins (third and fourth generation cephalosporins); cefotaxime or ceftriaxone, ceftazidime, cefepime; 4, cephamycins: cefoxitin; 5, quinolones: ciprofloxacin, levofloxacin; 6, folate pathway inhibitors: trimethoprim-sulphamethoxazole; 7, Penicillins + β-lactamase inhibitors: amoxicillin-clavulanic, ampicillin-sulbactam; 8, Phenicols: chloramphenicol.

Table 6

IntegronAntibioticχ2P-value
MDR* No. (%)Other isolates No. (%)
Integron +ve (N = 41)33 (64.7)9 (36)4.4910.017*
Integron −ve (N = 35)18 (35.3)16 (64)
Total51 (100)25 (100)

Relation between integron presence and MDR among Enterobactericae isolates.

χ2, Chi square test;

*

level of significans (p < 0.05).

Preliminary analysis using Chi square test revealed admission to ICU, trauma and hospitalization more than 7 days to be significantly correlated with integron positivity (Table 7). However, logistic regression analysis revealed no significant association (Table 8).

Table 7

Risk factorNo. of casesIntegron +veIntegron −veP-value
No%No%
Trauma553869.11730.90.029*
Hospitalization more than 7 days2017853150.011*
ICU admission342985.3514.70.002*
Ventilator108802200.235
Urinary catheter2872521750.357
Central venous catheter54801200.586

Association between risk factors and presence of integron (Chi square test).

*

Chi square test.

Table 8

VariableBS.E.WaldSig.OR
Trauma22.027.260.020.983.64 (0.07–5.15)
Hospitalization more than 7 days20.178.270.040.965.73 (1.02–7.45)
ICU admission42.031.100.030.900.01 (0.00–0.06)

Logistic regression analysis for significant predictors of the presence of integron among the studied groups.

B, Regression coefficients; S.E., standard error around the coefficient for the constant; Wald, Wald chi-square test statistic; Sig. P-value for Wald test; OR, odds ratio.

Discussion

Members of the family Enterobacteriaceae are frequently identified as etiological agents of nosocomial infections (Holt et al., 1994; Obeng-Nkrumah et al., 2013). Hospitalized patients, especially those admitted to ICUs, are at high risk (Archibald et al., 1997; El-Bialy and Abu-Zeid, 2009; Elsharkawy et al., 2013). This could explain the highest rate of isolating Enterobacteriaceae from the ICU encountered in the current work (Table 1), which support findings of others (Obeng-Nkrumah et al., 2013). In our study Klebsiella pneumoniae was the most commonly isolated organism, followed by Escherichia coli (Figure 1). This agrees with Abdel-Hady et al. (2008), Obeng-Nkrumah et al. (2013) and Defife et al. (2009), but disagrees with Asencio et al. (2014). The differences can be due to variations in study population, sample size, the presence of an epidemic as well as dissimilarities in antibiotic use.

The rate of integron-positive Enterobacteriaceae identified in this work is 53.9% compared to what was previously reported (White et al., 2001; Kor et al., 2013). We found the highest percentage of integrons in Escherichia coli (83.3%) which correlate with the report of Essen-Zandbergen et al. (2007), but not with Daikos et al. (2007) (Table 2). This could be attributed to diverse geographical distribution. The predominance of class I integrons among our isolates agree with many workers (Chang et al., 2000; White et al., 2001; Kor et al., 2013).

PCR product of cassette regions of class I integron were sequenced. The cassette regions of three class I integrons could not be amplified, possibly due to the lack of a 3′-conserved segment or due to presence of early stop codon (Ramírez et al., 2010). It is worth mentioning that the number and combination of genes found in gene cassettes of our isolate are different from that reported by many other researchers (White et al., 2001; Leverstein-van Hall et al., 2002; Kang et al., 2005), which prove the effect of geographic difference on integron distribution (Yu et al., 2004). Class II integons were excluded from sequencing analysis due to the very small sample size which limits the power of any conclusions (Table 3).

In this study, class I integrons harbored different cassette arrays conferring resistance to nearly every major class of antibiotics, with the remarkable exception of the quinolones (Daikos et al., 2007; Essen-Zandbergen et al., 2007). The most common types were those conferring resistance to trimethoprim antibiotic (dfr) a finding in agreement with Daikos et al. (2007) and Essen-Zandbergen et al. (2007). The high prevalence of dfr gene cassettes may be due to the wide use of trimethoprim as a first line therapy for the treatment of urinary tract infections, a clinical condition that is very common in both hospital and community settings. Another common types of cassette carried by class I integrons were those conferring resistance to streptomycin and spectinomycin (White et al., 2001). Aminoglycoside resistance genes (aadB, aac, and aph) encoding resistance to aminoglycosides other than streptomycin and spectinomycin (gentamicin, kanamycin, and amikacin) were found in 11 of our isolates. The selective pressure exerted by aminoglycosides intensively used in our hospitals might account for this finding (Table 3). Resistance to beta-lactam antibiotic was represented in this work by four cassettes (bla OXA 129-OXA 1-TEM-blaP1). To the best of our knowledge, bla OXA 129 is detected for the first time in Egypt. Till date, only two reports are available on the presence of OXA 129 in Gram-negative bacteria. The first was in 2008 from Brazil, from Salmonella enterica subsp. enterica serovar Bredeney porcine isolates (Michael et al., 2008), and the second was from China, in 2010 from Pseudomonas aeruginosa (Liu et al., 2010). The blaOXA-1 gene was found in two of our isolates. All the genes for the OXA-1-like beta-lactamases were identified in the form of gene cassettes inserted into class I integrons (Naas and Nordmann, 1999; Aubert et al., 2001; Dubois et al., 2003; Poirel et al., 2004). Other cassettes detected were those for erythromycin (ereA2), and for rifampicin resistance. These two gene cassettes were identified relatively more recently than the other cassettes (Jones et al., 1997; Tribuddharat and Fennewald, 1999; Leverstein-van Hall et al., 2002). The ereA gene cassette carries its own promoter and is propagated by a class II integron (Biskri and Mazel, 2003). Recently, a cassette carrying a gene and showing about 90% identity with ereA was identified in a class I multi-resistant integron (MRI) (Chang et al., 2000; Peters et al., 2001; Thungapathra et al., 2002; Plante et al., 2003). In this study, the occurrence of ereA gene carried on class I integron on four isolates (Table 3) is reported in Egypt for the first time. Chloramphenicol resistance protein (exporter), (cmiA5), were detected in two isolates. This gene is responsible for a less prevalent non-enzymatic mechanism of chloramphenicol resistance observed principally in Gram-negative bacteria (Bissonnette et al., 1991). The extremely low occurrence of chloramphenicol resistance, through a less prevalent mechanism presented by gene cassettes of our isolates, can be explained by the fact that chloramphenicol is no more prescribed in hospitals for the fear of its complications. Cassette (qac-e) which encodes for quaternary ammonium compounds resistance was detected in three of our isolates. In Enterobacteriaceae, the qac genes have been most regularly found together with genes coding for resistance to chloramphenicol, aminoglycosides, beta-lactams, sulphonamides and trimethoprim (Poirel et al., 2000; Riaño et al., 2006; Espedido et al., 2008; Zhao et al., 2012). In our work, qac-e has been found together with genes encoding resistance to aminoglycosides, and sulphonamides (Table 3). The correlation between the qac genes and macrolide inactivation genes was reported in Aeromonas hydrophila (Poole et al., 2006) and in microflora from a wastewater treatment unit (Szczepanowski et al., 2004). Hence, the use of several cationic biocides may also be accountable for the selection of bacteria resistant to antimicrobials (Russell, 2000).

It is worth mentioning that not only particular genes are shared across species but also some gene combinations. In the current work, dfrA5 was present across Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis, Enterobacter cloaca, and Proteus vulgaris. Gene combination, aadA1-dfrA1, was identified in Klebsiella pneumonia and Escherichia coli; the combination comprised of ereA2-dfrA5 was detected in Escherichia coli and Proteus mirabilis (Table 3). We also observed the presence of more than one isolate of Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis carrying a particular integron (Table 3). Since all these gene cassettes are carried by class I integron which contains integrase 1 (conserved sequence) (White et al., 2001), the transfer of the integrons by both intra- and inter-species is assumed. Integron spread may be achieved through the cross-transmission of integron-carrying clones from one patient to the other, an action known to be facilitated among Enterobacteriaceae in hospital settings (Leverstein-van Hall et al., 2002). This is particularly important in the background of poor compliance with infection control in our hospital.

The phenotypic resistance to a specific drug was observed in all isolates carrying the corresponding gene cassette; this coincides with Leverstein-van Hall et al. (2002); Barlow et al. (2004); Kor et al. (2013), and Li et al. (2013). However, it is also evident that integron-carrying organisms had reduced susceptibility not only to antimicrobial agents for which the respective gene cassettes were contained in but also to other classes of agents for which no or very little number of genes are contained within the integrons. In the current work, this applies to the third generation cephalosporins, chloramphenicol, and quinolones. Thus, we support the finding of previous investigators (White et al., 2001; Leverstein-van Hall et al., 2002; Essen-Zandbergen et al., 2007) regarding cephalosporins. Remarkably, not all the resistance profile of the isolates could be explained by the expression of the gene cassettes found within the integrons. Apparently a considerable number of antibiotic resistance genes are located outside the integrons either on chromosomes or plasmids.

More than half of our isolates were MD-resistant (Tables 5, 6) which has also been concluded by other workers (Elsharkawy et al., 2013; Ali et al., 2014). Just as reported by Partridge et al. (2009), class I integrons are significantly associated with MDR.

Logistic regression analysis for risk factors of the presence of integron among the studied group revealed statistically non-significant results (Table 8), which correlate with findings of Daikos et al. (2007). It may be due to small sample size. Hence, further investigation on a larger sample size is recommended.

We conclude that integrons carrying gene cassettes encoding antibiotic resistance are significantly present among Enterobacteriaceae causing nosocomial infection in our hospital. We also report for the first time in Egypt the detection of blaOXA129 and the carriage of ereA gene on class I integrons. These existences have important implications. Unless the use of antimicrobials in our hospital is rationalized, the emergence and the dissemination of these genes as well as other encoding resistance to more antibiotics will be evident in the future. Our study has renewed interest in the use of chloramphenicol since it is an effective and a cheap antimicrobial. In low-income countries, the use of chloramphenicol should be encouraged. The use of several cationic biocides should also be appropriate, since inappropriate usage may account for the selection of bacteria resistant to antimicrobials. A significant relationship was found between integron and MD-resistant phenotype. It is to be emphasized that the continuing use of antibiotics will drive the numbers of MDR to swell. The risk factors of integron carriage need to be identified. Our study is providing the base-line information that can be helpful in further monitoring and for evaluation.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Statements

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1

    Abdel-HadyH.HawasS.El-DakerM. E.El-KadyR. (2008). Extended spectrum beta lactamases producing Klebsiella pnemoniae in neonatal ICU. J. Perinat. 28, 685690. 10.1038/jp.2008.73

  • 2

    AliN. E.MorsiS. S.ElgoharyE. A. (2014). Association between antibiotics and disinfectants resistance profiles among Acinetobacter baumanni isolates in Zagazig University Hospital's intensive care unit. Life Sci. J. 11, 18. 10.7537/j.issn.1097-8135

  • 3

    ArchibaldL.PhillipsL.MonnetD.McGowanJ. E.TenoverF. C.GaynesR. P. (1997). Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin. Inf. Dis. 24, 211215. 10.1093/clinids/24.2.211

  • 4

    AsencioM. Á.HuertasM.CarranzaR.FrancoM.CastellanosJ.BarberáJ. R.et al. (2014). Trend in the susceptibility of the most frequent bacterial pathogens isolated at hospital general La Mancha Centro over 2010–2012 period. Rev. Esp. Quimioter. 27, 261268.

  • 5

    AubertD.PoirelL.ChevalierJ.LéotardS.PagèsJ.NordmannP. (2001). Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45, 16151620. 10.1128/AAC.45.6.1615-1620.2001

  • 6

    BarlowR. S.PembertonJ. M.DesmarchelierP. M.GobiusK. S. (2004). Isolation and characterization of integron-containing bacteria without antibiotic selection. Antimicrob. Agents Chemother. 48, 838842. 10.1128/AAC.48.3.838-842.2004

  • 7

    BiskriL.MazelD. (2003). Erythromycin esterase gene ere(A) is located in a functional gene cassette in an unusual class 2 integron. Antimicrob. Agents Chemother. 47, 33263331. 10.1128/AAC.47.10.3326-3331.2003

  • 8

    BissonnetteL.ChampetierS.BuissonJ.RoyH. (1991). Characterization of the nonenzymatic chloramphenicol resistance (cmlA) gene of the 1n4 integron of Tn1696: similarity of the product to transmembrane transport proteins. J. Bacteriol. 173, 44934502.

  • 9

    Cergole-NovellaM. C.PignatariA. C.CastanheiraM.GuthB. E. (2011). Molecular typing of antimicrobial-resistant Shiga-toxin-producing Escherichia coli strains (STEC) in Brazil. Res. Microbiol. 162, 117123. 10.1016/j.resmic.2010.09.022

  • 10

    ChangC.ChangL.ChangY.LeeT.ChangS. (2000). Characterization of drug resistance gene cassettes associated with class 1 integrons in clinical isolates of Escherichia coli from Taiwan, ROC. J. Med. Microbiol. 49, 10971102.

  • 11

    CheesbroughM. (2004). Culturing blood, in District Laboratory Practice in Tropical Countries. Part 2 (low-priced Egyptian Edn). ed CheesbroughM. (London: Cambridge University Press), 124127.

  • 12

    CLSI. (2013). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. CLSI document M100–S23. Wayne, PA: Clinical and Laboratory Standards Institute.

  • 13

    ColleeJ.MarrW. (1996). Blood culture, in MacKie and McCartney's Practical Medical Microbiology, 14th Edn., eds ColleeJ.FraserA.MarimonB.SimmonsA. (New York, NY: Churchill Livingstone), 120123.

  • 14

    DaikosG. L.KosmidisC.TassiosP. T.PetrikkosG.VasilakopoulouA.PsychogiouM.et al. (2007). Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome. Antimicrob. Agents Chemother. 51, 23662372. 10.1128/AAC.00044-07

  • 15

    DefifeR.ScheetzM. H.FeinglassJ. M.PostelnickM. J.ScarsiK. K. (2009). Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin. Antimicrob. Agents Chemother. 53, 10741079. 10.1128/AAC.00580-08

  • 16

    DeLappeN.O'HalloranF.FanningS.Corbett-FeeneyG.CheastyT.CormicanM. (2003). Antimicrobial resistance and genetic diversity of Shigella sonnei isolates from western Ireland, an area of low incidence of infection. J. Clin. Microbiol. 41, 19191924. 10.1128/JCM.41.5.1919-1924.2003

  • 17

    DuboisV.ArpinP.QuentinJ.Texier-MaugeinJ.PoirelL.NordmannP. (2003). Decreased susceptibility to cefepime in a clinical strain of Escherichia coli related to plasmid- and integron-encoded OXA-30 β-lactamase. Antimicrob. Agents Chemother. 47, 23802381. 10.1128/AAC.47.7.2380-2381.2003

  • 18

    El-BialyA. A.Abu-ZeidA. (2009). Prevalence and risk factors of extended-spectrum β lactamase producing Kelbsiella pneumoniae in neonatal intensive care unit. Egypt. J. of Med. Microbiol. 18, 279283.

  • 19

    ElsharkawyA.ElkadyL.MansourS.EsmaeelN. (2013). Detection of extended-spectrum and plasmid-mediated AmpC β-lactamases in nosocomial Klebsiella isolates. J. Microbiol. Infect. Dis. 3, 2430. 10.5799/ahinjs.02.2013.01.0074

  • 20

    EspedidoB. A.PartridgeS. R.IredellJ. R. (2008). Bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia. Antimicrob. Agents Chemother. 52, 29842987. 10.1128/AAC.01634-07

  • 21

    Essen-ZandbergenV. A.SmithH.VeldmanK.MeviusD. (2007). Occurrence and characteristics of class 1, 2 and 3 integrons in Escherichia coli, Salmonella and Campylobacter spp. in the Netherlands. J. Antimicrob. Chemother. 59, 746750. 10.1093/jac/dkl549

  • 22

    ForbesB. A.SahmD. F.WeissfeldA. S. (2007). Overview of bacterial identification methods and strategies, in Bailey and Scott's diagnostic microbiology12th Edn., eds AllenA.WilsonL.WurmE. (Philadelphia, PA: Mosby Elsevier), 216247.

  • 23

    GillingsM. R. (2014). Integrons: past, present, and future. Microbiol. Mol. Biol. Rev. 78, 257. 10.1128/MMBR.00056-13

  • 24

    HallR. M.CollisC. M. (1995). Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob. Agents Cbemother. 39, 155162. 10.1128/AAC.39.1.155

  • 25

    HoltJ.KriegN.SneathP.StaleJ.WilliamsS. (1994). Bergey's Manual of Determinative Bacteriology, 9th Edn. Baltimore, MD: Williams & Wilkins.

  • 26

    HoranT.AndrusM.DudeckM. (2008). CDC/NHSH surveillance definition of health care associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control. 36, 309332. 10.1016/j.ajic.2008.03.002

  • 27

    JonesM. E.PetersE.WeersinkA. M.FluitA. C.VerhoefJ. (1997). Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria. Lancet349, 17421743. 10.1016/S0140-6736(05)62954-6

  • 28

    KangH. Y.JeongY. S.OhY. U.TaeS. H.ChoiC. H.MoonD. C.et al. (2005). Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea. J. Antimicrob. Chemother. 55, 639644. 10.1093/jac/dki076

  • 29

    KeX.GuB.PanS.TongM. (2011). Epidemiology and molecular mechanism of integron-mediated antibiotic resistance in Shigella. Arch. Microbiol. 193, 767774. 10.1007/s00203-011-0744-3

  • 30

    KorS. B.ChooQ.ChewC. H. (2013). New integron gene arrays from multiresistant clinical isolates of members of the Enterobacteriaceae and Pseudomonas aeruginosa from hospitals in Malaysia. J. Med. Microbiol. 62, 412420. 10.1099/jmm.0.053645-0

  • 31

    Leverstein-van HallM. A.BoxA. T.BlokH. E.PaauwA.FluitA. C.VerhoefJ. (2002). Evidence of extensive interspecies transfer of integron−mediated antimicrobial resistance genes among multidrug resistant Enterobacteriaceae in a clinical setting. J. Infect. Dis. 186, 4956. 10.1086/341078

  • 32

    LiB.HuY.WangQ.YiY.WooP.JingH.et al. (2013). Structural diversity of class 1 integrons and their associated gene cassettes in Klebsiella pneumoniae isolates from a hospital in China. J. Med. Microbiol. 8:e75805. 10.1371/journal.pone.0075805

  • 33

    LiuW.LiuX.LiaoJ.ZhangY.LiangX. (2010). Identification of bla OXA-128 and bla OXA-129, two novel OXA-type extended-spectrum-β-lactamases in Pseudomonas aeruginosa, in human Province, China. J. Basic Microbiol. 50(Suppl. 1), S116S119. 10.1002/jobm.201000181

  • 34

    MagiorakosA. P.SrinivasanA.CareyR. B.CarmeliY.FalagasM. E.GiskeC. G.et al. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance A.-P. European Centre for Disease Prevention and Control, Stockholm, Sweden. Clin. Microbiol. Inf. 18, 3. 10.1111/j.1469-0691.2011.03570.x

  • 35

    MazelD. (2006). Integrons: agents of bacterial evolution. Nat. Rev. Microbiol. 4, 608620. 10.1038/nrmicro1462

  • 36

    MichaelG. B.CardosoM.SchwarzS. (2008). Molecular analysis of multiresistant porcine Salmonella enterica subsp. enterica serovar Bredeney isolates from southern Brazil: identification of resistance genes, integrons and a group II intron. Int. J. Antimicrob. Agents32, 120129. 10.1016/j.ijantimicag.2008.02.024

  • 37

    NaasT.NordmannP. (1999). OXA-type β-lactamases. Curr. Pharm. Des. 5, 865879.

  • 38

    Obeng-NkrumahN.Twum-DansoK.KrogfeltK.NewmanM. J. (2013). High levels of extended-spectrum beta-lactamases in a major teaching hospital in Ghana: the need for regular monitoring and evaluation of antibiotic resistance. Am. J. Trop. Med. Hyg. 89, 960964. 10.4269/ajtmh.12-0642

  • 39

    PartridgeS. R.TsafnatG.CoieraE.IredellR. J. (2009). Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol. Rev. 33, 757784. 10.1111/j.1574-6976.2009.00175.x

  • 40

    PaulsenI. T.LittlejohnT. G.RådströmP.SundströmL.SköldO.SwedbergG.et al. (1993). The 3 conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants. Antimicrob. Agents Chemother. 37, 761768. 10.1128/AAC.37.4.761

  • 41

    PetersE. D.Leverstein-van HallM. A.BoxA. T.VerhoefJ.Fluit.A. C. (2001). Novel gene cassettes and integrons. Antimicrob. Agents Chemother. 45, 29612964. 10.1128/AAC.45.10.2961-2964.2001

  • 42

    PlanteI.CentronD.RoyP. H. (2003). An integron cassette encoding erythromycin esterase, ere(A), from Providencia stuartii. J. Antimicrob. Chemother. 51, 787790. 10.1093/jac/dkg169

  • 43

    PoirelL.HéritierC.TolünV.NordmannP. (2004). Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48, 1522. 10.1128/AAC.48.1.15-22.2004

  • 44

    PoirelL.Le ThomasI.NaasT.KarimA.NordmannP. (2000). Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44, 622632. 10.1128/AAC.44.3.622-632.2000

  • 45

    PooleT. L.CallawayT. R.BischoffK. M.WarnesC. E.NisbetD. J. (2006). Macrolide inactivation gene cluster mphAmrx-mphR adjacent to a class 1 integron in Aeromonas hydrophila isolated from a diarrhoeic pig in Oklahoma. J. Antimicrob. Chemother. 57, 3138. 10.1093/jac/dki421

  • 46

    RamírezM. S.PiñeiroS.CentrónD. (2010). Novel insights about class 2 integrons from experimental and genomic epidemiology. Antimicrob. Agents Chemother. 54, 699706. 10.1128/AAC.01392-08

  • 47

    RaulR. M.MelvinP. W. (2001). Laboratory diagnosis of bacteremia and fungemia. Infect. Dis. Clin. North Am. 15, 125.

  • 48

    RiañoI.MorenoM. A.TeshagerT.SáenzY.DomínguezL.TorresC. (2006). Detection and characterization of extended-spectrum beta-lactamases in Salmonella enterica strains of healthy food animals in Spain. J. Antimicrob. Chemother. 58, 844847. 10.1093/jac/dkl337

  • 49

    Rodríguez-MinguelaC. M.ApajalahtiJ. H.ColeJ. R.TiedjeJ. M. (2009). Worldwide prevalence of class 2 integrases outside the clinical setting is associated with human impact. Appl. Environ. Microbiol. 75, 1625. 10.1128/aem.00133-09

  • 50

    RussellA. D. (2000). Do biocides select for antibiotic resistance?J. Pharm. Pharmacol. 52, 227233. 10.1211/0022357001773742

  • 51

    SurzyckiS. (2000). PCR, in Basic Techniques in Molecular Biology, ed SurzyckiS. (Berlin: Springer-Velag), 163164. 10.1007/978-3-642-56968-5_8

  • 52

    SzczepanowskiR.KrahnI.LinkeB.GoesmannA.PuhlerA.SchluterA. (2004). Antibiotic multiresistance plasmid pRSB101 isolated from a wastewater treatment plant is related to plasmids residing in phytopathogenic bacteria and carries eight different resistance determinants including a multidrug transport system. Microbiology150, 36133630. 10.1099/mic.0.27317-0

  • 53

    ThungapathraM.AmitaK.SinhaK.ChaudhuriS. R.GargP.RamamurthyT.et al. (2002). Occurrence of antibiotic resistance gene cassettes aac(6')-Ib, dfrA5, dfrA12, and ereA2 in class I integrons in non-O1, non-O139 Vibrio cholerae strains in India. Antimicrob. Agents Chemother. 46, 29482955. 10.1128/AAC.46.9.2948-2955.2002

  • 54

    TribuddharatC.FennewaldM. (1999). Integron-mediated rifampin resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43, 960962.

  • 55

    WhiteP. A.McIverC. J.DengY.RawlinsonW. D. (2000). Characterization of the two gene cassettes aadA5 and dfrA17. FEMS Microbiol. Lett. 182, 265269. 10.1111/j.1574-6968.2000.tb08906.x

  • 56

    WhiteP. A.McIverC. J.RawlinsonW. D. (2001). Integrons and gene cassettes in the enterobacteriaceae. Antimicrob Agents Chemother. 45, 26582661. 10.1128/AAC.45.9.2658-2661.2001

  • 57

    YuH. S.LeeJ. C.KangH. Y.JeongY. S.LeeE. Y.ChoiC. H.et al. (2004). Prevalence of dfr genes associated with integrons and dissemination of dfrA17 among urinary isolates of Escherichia coli in Korea. J. Antimicrob. Chemother. 53, 445450. 10.1093/jac/dkh097

  • 58

    ZhaoW. H.ChenG. L.ItoR.KimuraS.HuZ. Q. (2012). Identification of a plasmid-borne bla(IMP-11) gene in clinical isolates of Escherichia coli and Klebsiella pneumoniae. J. Med. Microbiol. 61, 246251. 10.1099/jmm.0.035626-0

Summary

Keywords

integron, Enterobacteriaceae, MDR, risk factors, sequencing

Citation

Malek MM, Amer FA, Allam AA, El-Sokkary RH, Gheith T and Arafa MA (2015) Occurrence of classes I and II integrons in Enterobacteriaceae collected from Zagazig University Hospitals, Egypt. Front. Microbiol. 6:601. doi: 10.3389/fmicb.2015.00601

Received

27 February 2015

Accepted

01 June 2015

Published

23 June 2015

Volume

6 - 2015

Edited by

Ghassan M. Matar, American University of Beirut, Lebanon

Reviewed by

M. Pilar Francino, Fomento de la Investigación Sanitaria y Biomédica_Public Health, Spain; Carmen Losasso, Istituto Zooprofilattico Sperimentale delle Venezie, Italy; Steve M. Harakeh, King Abdulaziz University, Saudi Arabia

Copyright

*Correspondence: Fatma A. Amer, Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, 9A Road 275, New Maadi, 11343 Cairo, Egypt

This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics